The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Tarasov S.A.

Sklifosovsky Research Institute for Emergency Care

Yartsev P.A.

Sklifosovsky Research Institute for Emergency Care

Rogal M.M.

Sklifosovsky Research Institute for Emergency Care

Aksenova S.O.

Sklifosovsky Research Institute for Emergency Care

Complicated gastric cancer and modern treatment approaches

Authors:

Tarasov S.A., Yartsev P.A., Rogal M.M., Aksenova S.O.

More about the authors

Journal: Pirogov Russian Journal of Surgery. 2024;(4): 125‑140

Read: 2195 times


To cite this article:

Tarasov SA, Yartsev PA, Rogal MM, Aksenova SO. Complicated gastric cancer and modern treatment approaches. Pirogov Russian Journal of Surgery. 2024;(4):125‑140. (In Russ.)
https://doi.org/10.17116/hirurgia2024041125

Recommended articles:
Pancreaticoduodenectomy combined with multivisceral rese­ctions. Piro­gov Russian Journal of Surgery. 2024;(11):77-83
Intraoperative left ventricular rupture in cardiac surgery. Piro­gov Russian Journal of Surgery. 2025;(4):95-99
A clinical case of successful treatment of stage IV gastric cancer. P.A. Herzen Journal of Onco­logy. 2024;(5):54-58
Perioperative prevention of bleeding in glaucoma surgery. Russian Annals of Ophthalmology. 2024;(5):118-124
Claudin-18.2 and gastric cancer: from physiology to carcinogenesis. Russian Journal of Archive of Pathology. 2024;(6):92-99
Gastric cancer: inci­dence, risk factors, screening. Russian Journal of Preventive Medi­cine. 2024;(12):135-139

References:

  1. Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, Farjah F, Gerdes H, Gibson MK, Hochwald S, Hofstetter WL, Ilson DH, Keswani RN, Kim S, Kleinberg LR, Klempner SJ, Lacy J, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Outlaw D, Park H, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian N, Pluchino LA. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2022;20(2):167-192.  https://doi.org/10.6004/jnccn.2022.0008
  2. Kim SG, Seo HS, Lee HH, Song KY, Park CH. Comparison of the Differences in Survival Rates between the 7th and 8th Editions of the AJCC TNM Staging System for Gastric Adenocarcinoma: a Single-Institution Study of 5,507 Patients in Korea. Journal of Gastric Cancer. 2017;17(3):212.  https://doi.org/10.5230/jgc.2017.17.e23
  3. Machlowska J, Baj J, Sitarz M, Maciejewski R, Sitarz R. Gastric Cancer: Epidemiology, Risk Factors, Classification, Genomic Characteristics and Treatment Strategies. International Journal of Molecular Sciences. 2020;21(11). https://doi.org/10.3390/ijms21114012
  4. Morgan E, Arnold M, Camargo MC, Gini A, Kunzmann AT, Matsuda T, Meheus F, Verhoeven RHA, Vignat J, Laversanne M, Ferlay J, Soerjomataram I. The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: A population-based modelling study. EClinicalMedicine. 2022;47:101404. https://doi.org/10.1016/j.eclinm.2022.101404
  5. Sekiguchi M, Oda I, Matsuda T, Saito Y. Epidemiological Trends and Future Perspectives of Gastric Cancer in Eastern Asia. Digestion. 2022;103(1):22-28.  https://doi.org/10.1159/000518483
  6. Sitarz R, Skierucha M, Mielko J, Offerhaus GJA, Maciejewski R, Polkowski WP. Gastric cancer: epidemiology, prevention, classification, and treatment. Cancer Management and Research. 2018;10:239-248.  https://doi.org/10.2147/CMAR.S149619
  7. Arnold M, Park JY, Camargo MC, Lunet N, Forman D, Soerjomataram I. Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035. Gut. 2020;69(5):823-829.  https://doi.org/10.1136/gutjnl-2019-320234
  8. Kaprin AD, Starinskiy VV, Shakhzadova AO. Zlokachestvennyye novoobrazovaniya v Rossii v 2020 godu (zabolevayemost’ i smertnost’). M.: MNIOI im. P.A. Gertsena − filial FGBU «NMITS radiologii» Minzdrava Rossii; 2021. (In Russ.).
  9. Ford AC, Yuan Y, Moayyedi P. Helicobacter pylori eradication therapy to prevent gastric cancer: systematic review and meta-analysis. Gut. 2020;69(12):2113-2121. https://doi.org/10.1136/gutjnl-2020-320839
  10. Sheptulin AA, Rabotyagova YuS. Rol’ eradikatsii Helicobacter pylori v profilaktike razvitiya raka zheludka (po materialam soglasitel’nogo soveshchaniya «Maastrikht-VI»). Klinicheskaya meditsina. 2023;101(4-5):229-234. (In Russ.). https://doi.org/10.30629/0023-2149-2023-101-4-5-229-234
  11. Markovich VA, Tuzikov SA, Rodionov YeO. Kombinirovannoye lecheniye bol’nykh rakom zheludka IV stadii s kantseromatozom bryushiny. Sibirskii onkologicheskii zhurnal. 2023;22(1):24-34. (In Russ.). https://doi.org/10.21294/1814-4861-2023-22-1-24-34
  12. Stilidi IS, Sigua BV, Zemlyanoy VP. Rak zheludka, oslozhnennyy krovotecheniyem. (Sistematicheskiy obzor literatury). Khirurgiya. Zhurnal im. N.I. Pirogova. 2022;6:102-115. (In Russ.). https://doi.org/10.17116/hirurgia2022061102
  13. Sigua BV, Petrov SV, Gubkov II, Danilov AM, Zakharov YeA, Sakhno DS. Khirurgicheskaya taktika pri nemetastaticheskom rake zheludka, oslozhnennom krovotecheniyem. Moskovskiy khirurgicheskiy zhurnal. 2018;3(61):55-56. (In Russ.).
  14. Shabunin AV, Grekov DN, Yakomaskin VN, Tsurkan VA, Kuz’menko AA, Kurdyukov KS, Bako RO. Opyt lecheniya krovotecheniy u bol’nykh s «prodvinutymi» formami raka zheludka. Zlokachestvennyye opukholi. 2021;11(3S1):48. (In Russ.).
  15. Akhmetzyanov FSh, Valiullin II, Akhmetzyanova FF. Issues of diagnosis and treatment of complicated gastric cancer. Povolzhsky Oncological Bulletin. 2022;2(50):80-92. (In Russ.).
  16. Dibirov MD, Khalidov OKh, Zakaraya AYe. Rak zheludka, oslozhnennyy perforatsiyey i stenozom, v usloviyakh neotlozhnoy khirurgii organov bryushnoy polosti. Moskovskiy khirurgicheskiy zhurnal. 2010;5(15):7-10. (In Russ.).
  17. Hansford S, Kaurah P, Li-Chang H, Woo M, Senz J, Pinheiro H, Schrader KA, Schaeffer DF, Shumansky K, Zogopoulos G, Santos TA, Claro I, Carvalho J, Nielsen C, Padilla S, Lum A, Talhouk A, Baker-Lange K, Richardson S, Lewis I, Lindor NM, Pennell E, MacMillan A, Fernandez B, Keller G, Lynch H, Shah SP, Guilford P, Gallinger S, Corso G, Roviello F, Caldas C, Oliveira C, Pharoah PD, Huntsman DG. Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond. JAMA Oncology. 2015;1(1):23-32.  https://doi.org/10.1001/jamaoncol.2014.168
  18. Wang HB, Liao XF, Zhang J. Clinicopathological factors associated with HER2-positive gastric cancer: A meta-analysis. Medicine. 2017;96(44):e8437. Erratum in: Medicine. 2017;96(52):e9530. https://doi.org/10.1097/MD.0000000000008437
  19. Wu J, Liu X, Cai H, Wang Y. Prediction of tumor recurrence after curative resection in gastric carcinoma based on bcl-2 expression. World Journal of Surgical Oncology. 2014;12:40.  https://doi.org/10.1186/1477-7819-12-40
  20. Polom K, Marrelli D, Smyth EC, Voglino C, Roviello G, Pascale V, Varas J, Vindigni C, Roviello F. The Role of Microsatellite Instability in Positive Margin Gastric Cancer Patients. Surgical Innovation. 2018;25(2):99-104.  https://doi.org/10.1177/1553350617751461
  21. Feng F, Tian Y, Xu G, Liu Z, Liu S, Zheng G, Guo M, Lian X, Fan D, Zhang H. Diagnostic and prognostic value of CEA, CA19-9, AFP and CA125 for early gastric cancer. BMC Cancer. 2017;17(1):737.  https://doi.org/10.1186/s12885-017-3738-y
  22. Sawayama H, Iwatsuki M, Kuroda D, Toihata T, Uchihara T, Koga Y, Yagi T, Kiyozumi Y, Eto T, Hiyoshi Y, Ishimoto T, Baba Y, Miyamoto Y, Yoshida N, Baba H. The association of the lymph node ratio and serum carbohydrate antigen 19-9 with early recurrence after curative gastrectomy for gastric cancer. Surgery Today. 2018;48(11):994-1003. https://doi.org/10.1007/s00595-018-1684-1
  23. Hasbahceci M, Malya FU, Kunduz E, Guzel M, Unver N, Akcakaya A. Use of serum and peritoneal CEA and CA19-9 in prediction of peritoneal dissemination and survival of gastric adenocarcinoma patients: are they prognostic factors? Annals of the Royal College of Surgeons of England. 2018;100(4):257-266.  https://doi.org/10.1308/rcsann.2018.0011
  24. Kuvaev, R.O. Early gastric cancer: modern methods of screening, endoscopic diagnosis and minimally invasive treatment/R. O. Kuvaev, S. V. Kashin, E. L. Nikonov, T. Itoh, T. Gotoda, K. Gono//Evidence-based gastroenterology. 2014;3(3):44-51. 
  25. Young E, Philpott H, Singh R. Endoscopic diagnosis and treatment of gastric dysplasia and early cancer: Current evidence and what the future may hold. World Journal of Gastroenterology. 2021;27(31):5126-5151. https://doi.org/10.3748/wjg.v27.i31.5126
  26. Choi J, Kim SG, Im JP, Kim JS, Jung HC, Song IS. Endoscopic prediction of tumor invasion depth in early gastric cancer. Gastrointestinal Endoscopy. 2011;73(5):917-927.  https://doi.org/10.1016/j.gie.2010.11.053
  27. Zhang Q, Wang F, Chen ZY, Wang Z, Zhi FC, Liu SD, Bai Y. Comparison of the diagnostic efficacy of white light endoscopy and magnifying endoscopy with narrow band imaging for early gastric cancer: a meta-analysis. Gastric Cancer. 2016;19(2):543-552.  https://doi.org/10.1007/s10120-015-0500-5
  28. Capelle LG, Haringsma J, de Vries AC, Steyerberg EW, Biermann K, van Dekken H, Kuipers EJ. Narrow band imaging for the detection of gastric intestinal metaplasia and dysplasia during surveillance endoscopy. Digestive Diseases and Sciences. 2010;55(12):3442-3448. https://doi.org/10.1007/s10620-010-1189-2
  29. Pimentel-Nunes P, Libânio D, Lage J, Abrantes D, Coimbra M, Esposito G, Hormozdi D, Pepper M, Drasovean S, White JR, Dobru D, Buxbaum J, Ragunath K, Annibale B, Dinis-Ribeiro M. A multicenter prospective study of the real-time use of narrow-band imaging in the diagnosis of premalignant gastric conditions and lesions. Endoscopy. 2016;48(8):723-730.  https://doi.org/10.1055/s-0042-108435
  30. Hu YY, Lian QW, Lin ZH, Zhong J, Xue M, Wang LJ. Diagnostic performance of magnifying narrow-band imaging for early gastric cancer: A meta-analysis. World Journal of Gastroenterology. 2015;21(25):7884-7894. https://doi.org/10.3748/wjg.v21.i25.7884
  31. Weigt J, Malfertheiner P, Canbay A, Haybaeck J, Bird-Lieberman E, Link A. Blue Light Imaging and Linked Color Imaging for the Characterization of Mucosal Changes in Chronic Gastritis: A Clinicians View and Brief Technical Report. Digestive Diseases. 2020;38(1):9-14.  https://doi.org/10.1159/000501265
  32. Dohi O, Yagi N, Naito Y, Fukui A, Gen Y, Iwai N, Ueda T, Yoshida N, Kamada K, Uchiyama K, Takagi T, Konishi H, Yanagisawa A, Itoh Y. Blue laser imaging-bright improves the real-time detection rate of early gastric cancer: a randomized controlled study. Gastrointestinal Endoscopy. 2019;89(1):47-57.  https://doi.org/10.1016/j.gie.2018.08.049
  33. Shuleshova AG, Zav’yalov MO, Ul’yanov DN, Kanareytseva TD. Kombinirovannyye endoskopicheskiye metody diagnostiki s ispol’zovaniyem zondovoy konfokal’noy endomikroskopii v vyyavlenii neoplaziy zheludka. Khirurgiya. Zhurnal im. N.I. Pirogova. 2014;8:9-15. (In Russ.).
  34. Zhang HP, Yang S, Chen WH, Hu TT, Lin J. The diagnostic value of confocal laser endomicroscopy for gastric cancer and precancerous lesions among Asian population: a system review and meta-analysis. Scandinavian Journal of Gastroenterology. 2017;52(4):382-388.  https://doi.org/10.1080/00365521.2016.1275770
  35. Besova NS, Bolotina LV, Gamayunov SV, Kalinin AE, Kozlov NA, Malikhova OA, Nered SN, Protsenko SA, Stilidi IS, Ter-Ovanesov MD, Tryakin AA, Khomyakov VM, Pirogov SS, Chernykh MV. Practical recommendations for drug treatment of gastric cancer. Malignant tumors. 2022;12(3s2-1):382-400. (In Russ.). https://doi.org/10.18027/2224-5057-2022-12-3s2-382-400
  36. Kwee RM, Kwee TC. Modern imaging techniques for preoperative detection of distant metastases in gastric cancer. World Journal of Gastroenterology. 2015;21(37):10502-10509. https://doi.org/10.3748/wjg.v21.i37.10502
  37. Zhang Y, Yu J. The role of MRI in the diagnosis and treatment of gastric cancer. Diagnostic And Interventional Radiology. 2020;26(3):176-182.  https://doi.org/10.5152/dir.2019.19375
  38. Fiori E, Crocetti D, Sapienza P, Cirocchi R, Sterpetti AV, Miccini M, Accordino M, Costi S, Lapolla P, Mingoli A, De Toma G, Lamazza A. Palliative Surgery or Metallic Stent Positioning for Advanced Gastric Cancer: Differences in QOL. Medicina. 2021;57(5). https://doi.org/10.3390/medicina57050428
  39. Saito S, Hosoya Y, Togashi K, Kurashina K, Haruta H, Hyodo M, Koinuma K, Horie H, Yasuda Y, Nagai H. Prevalence of synchronous colorectal neoplasms detected by colonoscopy in patients with gastric cancer. Surgery Today. 2008;38(1):20-25.  https://doi.org/10.1007/s00595-007-3567-8
  40. Tao M, Zhou X, Hu M, Pan J. Endoscopic submucosal dissection versus endoscopic mucosal resection for patients with early gastric cancer: a meta-analysis. BMJ Open. 2019;9(12):e025803. https://doi.org/10.1136/bmjopen-2018-025803
  41. van Halsema EE, Rauws EAJ, Fockens P, van Hooft JE. Self-expandable metal stents for malignant gastric outlet obstruction: A pooled analysis of prospective literature. World Journal of Gastroenterology. 2015;21(43):12468-12481. https://doi.org/10.3748/wjg.v21.i43.12468
  42. Kim JJ, Lee JH, Jung HY, Lee GH, Cho JY, Ryu CB, Chun HJ, Park JJ, Lee WS, Kim HS, Chung MG, Moon JS, Choi SR, Song GA, Jeong HY, Jee SR, Seol SY, Yoon YB. EMR for early gastric cancer in Korea: a multicenter retrospective study. Gastrointestinal Endoscopy. 2007;66(4):693-700.  https://doi.org/10.1016/j.gie.2007.04.013
  43. Choi KS, Jung HY, Choi KD, Lee GH, Song HJ, Kim DH, Lee JH, Kim MY, Kim BS, Oh ST, Yook JH, Jang SJ, Yun SC, Kim SO, Kim JH. EMR versus gastrectomy for intramucosal gastric cancer: comparison of long-term outcomes. Gastrointestinal Endoscopy. 2011;73(5):942-948.  https://doi.org/10.1016/j.gie.2010.12.032
  44. Choi KS, Jung HY, Choi KD, Lee GH, Song HJ, Kim DH, Lee JH, Kim MY, Kim BS, Oh ST, Yook JH, Jang SJ, Yun SC, Kim SO, Kim JH. Short- and long-term outcomes of endoscopic submucosal dissection for undifferentiated early gastric cancer. Endoscopy. 2013;45(9):703-707.  https://doi.org/10.1055/s-0033-1344396
  45. Bausys R, Bausys A, Stanaitis J, Vysniauskaite I, Maneikis K, Bausys B, Stratilatovas E, Strupas K. Propensity score-matched comparison of short-term and long-term outcomes between endoscopic submucosal dissection and surgery for treatment of early gastric cancer in a Western setting. Surgical Endoscopy. 2019;33(10):3228-3237. https://doi.org/10.1007/s00464-018-06609-6
  46. Chang JY, Shim KN, Tae CH, Lee KE, Lee J, Lee KH, Moon CM, Kim SE, Jung HK, Jung SA, Lee JH, Cho MS. Comparison of clinical outcomes after endoscopic submucosal dissection and surgery in the treatment of early gastric cancer: A single-institute study. Medicine. 2017;96(30):e7210. https://doi.org/10.1097/MD.0000000000007210
  47. Hahn KY, Park CH, Lee YK, Chung H, Park JC, Shin SK, Lee YC, Kim HI, Cheong JH, Hyung WJ, Noh SH, Lee SK. Comparative study between endoscopic submucosal dissection and surgery in patients with early gastric cancer. Surgical Endoscopy. 2018;32(1):73-86.  https://doi.org/10.1007/s00464-017-5640-8
  48. Liu Q, Ding L, Qiu X, Meng F. Updated evaluation of endoscopic submucosal dissection versus surgery for early gastric cancer: A systematic review and meta-analysis. International Journal of Surgery. 2020;73:28-41.  https://doi.org/10.1016/j.ijsu.2019.11.027
  49. Bestetti AM, de Moura DTH, Proença IM, Junior ESDM, Ribeiro IB, Sasso JGRJ, Kum AST, Sánchez-Luna SA, Marques Bernardo W, de Moura EGH. Endoscopic Resection Versus Surgery in the Treatment of Early Gastric Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology. 2022;12:939244. https://doi.org/10.3389/fonc.2022.939244
  50. Kamarajah SK, Markar SR, Phillips AW, Salti GI, Dahdaleh FS. Local Endoscopic Resection is Inferior to Gastrectomy for Early Clinical Stage T1a and T1b Gastric Adenocarcinoma: A Propensity-Matched Study. Annals of Surgical Oncology. 2021;28(6):2992-2998. https://doi.org/10.1245/s10434-020-09485-4
  51. Zhao Y, Wang C. Long-Term Clinical Efficacy and Perioperative Safety of Endoscopic Submucosal Dissection versus Endoscopic Mucosal Resection for Early Gastric Cancer: An Updated Meta-Analysis. BioMed Research International. 2018;2018:3152346. https://doi.org/10.1155/2018/3152346
  52. Smirnov AS, Deribas KV, Mityunova AA. Modern aspects of surgical treatment of gastric cancer. Alley of Science. 2019;5(32):122-126. (In Russ.).
  53. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2018 (5th edition). Gastric Cancer. 2021;24(1):1-21.  https://doi.org/10.1007/s10120-020-01042-y
  54. Jeurnink SM, Steyerberg EW, van Hooft JE, van Eijck CH, Schwartz MP, Vleggaar FP, Kuipers EJ, Siersema PD; Dutch SUSTENT Study Group. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointestinal Endoscopy. 2010;71(3):490-499.  https://doi.org/10.1016/j.gie.2009.09.042
  55. Ajani JA, D’Amico TA, Bentrem DJ, Chao J, Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, Farjah F, Gerdes H, Gibson MK, Hochwald S, Hofstetter WL, Ilson DH, Keswani RN, Kim S, Kleinberg LR, Klempner SJ, Lacy J, Ly QP, Matkowskyj KA, McNamara M, Mulcahy MF, Outlaw D, Park H, Perry KA, Pimiento J, Poultsides GA, Reznik S, Roses RE, Strong VE, Su S, Wang HL, Wiesner G, Willett CG, Yakoub D, Yoon H, McMillian N, Pluchino LA. Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network. 2022;20(2):167-192.  https://doi.org/10.6004/jnccn.2022.0008
  56. Marano L, Rondelli F, Bartoli A, Testini M, Castagnoli G, Ceccarelli G. Oncologic Effectiveness and Safety of Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: Meta-analysis of Randomized Controlled Trials. Anticancer Research. 2018;38(6):3609-3617. https://doi.org/10.21873/anticanres.12635
  57. Csendes A, Burdiles P, Rojas J, Braghetto I, Diaz JC, Maluenda F. A prospective randomized study comparing D2 total gastrectomy versus D2 total gastrectomy plus splenectomy in 187 patients with gastric carcinoma. Surgery. 2002;131(4):401-407.  https://doi.org/10.1067/msy.2002.121891
  58. Yu W, Choi GS, Chung HY. Randomized clinical trial of splenectomy versus splenic preservation in patients with proximal gastric cancer. The British Journal of Surgery. 2006;93(5):559-563.  https://doi.org/10.1002/bjs.5353
  59. Sano T, Sasako M, Mizusawa J, Yamamoto S, Katai H, Yoshikawa T, Nashimoto A, Ito S, Kaji M, Imamura H, Fukushima N, Fujitani K; Stomach Cancer Study Group of the Japan Clinical Oncology Group. Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma. Annals of Surgery. 2017;265(2):277-283.  https://doi.org/10.1097/SLA.0000000000001814
  60. Hartgrink HH, van de Velde CJ, Putter H, Bonenkamp JJ, Klein Kranenbarg E, Songun I, Welvaart K, van Krieken JH, Meijer S, Plukker JT, van Elk PJ, Obertop H, Gouma DJ, van Lanschot JJ, Taat CW, de Graaf PW, von Meyenfeldt MF, Tilanus H, Sasako M. Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial. Journal of Clinical Oncology. 2004;22(11):2069-2077. https://doi.org/10.1200/JCO.2004.08.026
  61. Degiuli M, Sasako M, Ponti A, Italian Gastric Cancer Study Group. Morbidity and mortality in the Italian Gastric Cancer Study Group randomized clinical trial of D1 versus D2 resection for gastric cancer. The British Journal of Surgery. 2010;97(5):643-649.  https://doi.org/10.1002/bjs.6936
  62. Seevaratnam R, Bocicariu A, Cardoso R, Mahar A, Kiss A, Helyer L, Law C, Coburn N. A meta-analysis of D1 versus D2 lymph node dissection. Gastric Cancer. 2012;15(suppl 1):S60-69.  https://doi.org/10.1007/s10120-011-0110-9
  63. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. The Lancet. Oncology. 2010;11(5):439-449.  https://doi.org/10.1016/S1470-2045(10)70070-X
  64. Kurokawa Y, Doki Y, Mizusawa J, Terashima M, Katai H, Yoshikawa T, Kimura Y, Takiguchi S, Nishida Y, Fukushima N, Iwasaki Y, Kaji M, Hirao M, Katayama H, Sasako M. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial. The Lancet. Gastroenterology & Hepatology. 2018;3(7):460-468.  https://doi.org/10.1016/S2468-1253(18)30090-6
  65. Fujita J, Kurokawa Y, Sugimoto T, Miyashiro I, Iijima S, Kimura Y, Takiguchi S, Fujiwara Y, Mori M, Doki Y. Survival benefit of bursectomy in patients with resectable gastric cancer: interim analysis results of a randomized controlled trial. Gastric Cancer. 2012;15(1):42-48.  https://doi.org/10.1007/s10120-011-0058-9
  66. Katai H, Sasako M, Fukuda H, Nakamura K, Hiki N, Saka M, Yamaue H, Yoshikawa T, Kojima K; JCOG Gastric Cancer Surgical Study Group. Safety and feasibility of laparoscopy-assisted distal gastrectomy with suprapancreatic nodal dissection for clinical stage I gastric cancer: a multicenter phase II trial (JCOG 0703). Gastric Cancer. 2010;13(4):238-244.  https://doi.org/10.1007/s10120-010-0565-0
  67. Kim HH, Han SU, Kim MC, Kim W, Lee HJ, Ryu SW, Cho GS, Kim CY, Yang HK, Park DJ, Song KY, Lee SI, Ryu SY, Lee JH, Hyung WJ; Korean Laparoendoscopic Gastrointestinal Surgery Study (KLASS) Group. Effect of Laparoscopic Distal Gastrectomy vs Open Distal Gastrectomy on Long-term Survival Among Patients With Stage I Gastric Cancer: The KLASS-01 Randomized Clinical Trial. JAMA Oncology. 2019;5(4):506-513.  https://doi.org/10.1001/jamaoncol.2018.6727
  68. Inaki N, Etoh T, Ohyama T, Uchiyama K, Katada N, Koeda K, Yoshida K, Takagane A, Kojima K, Sakuramoto S, Shiraishi N, Kitano S. A Multi-institutional, Prospective, Phase II Feasibility Study of Laparoscopy-Assisted Distal Gastrectomy with D2 Lymph Node Dissection for Locally Advanced Gastric Cancer (JLSSG0901). World Journal of Surgery. 2015;39(11):2734-2741. https://doi.org/10.1007/s00268-015-3160-z
  69. Lin JX, Lin JL, Zheng CH, Li P, Xie JW, Wang JB, Lu J, Chen QY, Cao LL, Lin M, Tu RH, Huang ZN, Huang CM. Short- and long-term outcomes of laparoscopy-assisted versus open total gastrectomy for gastric cancer: a propensity score-matched analysis. Oncotarget. 2017;8(45):80029-80038. https://doi.org/10.18632/oncotarget.16852
  70. Hyung WJ, Yang HK, Park YK, Lee HJ, An JY, Kim W, Kim HI, Kim HH, Ryu SW, Hur H, Kim MC, Kong SH, Cho GS, Kim JJ, Park DJ, Ryu KW, Kim YW, Kim JW, Lee JH, Han SU; Korean Laparoendoscopic Gastrointestinal Surgery Study Group. Long-Term Outcomes of Laparoscopic Distal Gastrectomy for Locally Advanced Gastric Cancer: The KLASS-02-RCT Randomized Clinical Trial. Journal of Clinical Oncology. 2020;38(28):3304-3313. https://doi.org/10.1200/JCO.20.01210
  71. Yu J, Huang C, Sun Y, Su X, Cao H, Hu J, Wang K, Suo J, Tao K, He X, Wei H, Ying M, Hu W, Du X, Hu Y, Liu H, Zheng C, Li P, Xie J, Liu F, Li Z, Zhao G, Yang K, Liu C, Li H, Chen P, Ji J, Li G; Chinese Laparoscopic Gastrointestinal Surgery Study (CLASS) Group. Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial. JAMA. 2019;321(20):1983-1992. https://doi.org/10.1001/jama.2019.5359
  72. Sigua BV, Zemlyanoy VP, Gubkov II, Sakhno DS, Zakharov EA. Results and prospects of treatment of patients with non-metastatic gastric cancer complicated by bleeding. Bulletin of the National Medical and Surgical Center named after. N.I. Pirogov. 2017;12(2):85-88. (In Russ.).
  73. Fomin PD, Ivanchov PV. Aspects of treatment tactics and the place of clinical and endoscopic monitoring in the surgical treatment of acute bleeding malignant tumors of the stomach. Surgery. Eastern Europe. 2012;2(2):46-55. (In Russ.).
  74. Arena M, Masci E, Eusebi LH, Iabichino G, Mangiavillano B, Viaggi P, Morandi E, Fanti L, Granata A, Traina M, Testoni PA, Opocher E, Luigiano C. Hemospray for treatment of acute bleeding due to upper gastrointestinal tumours. Digestive and Liver Disease. 2017;49(5):514-517.  https://doi.org/10.1016/j.dld.2016.12.012
  75. Meehan T, Stecker MS, Kalva SP, Oklu R, Walker TG, Ganguli S. Outcomes of transcatheter arterial embolization for acute hemorrhage originating from gastric adenocarcinoma. Journal of Vascular and Interventional Radiology. 2014;25(6):847-851.  https://doi.org/10.1016/j.jvir.2014.02.005
  76. Kim Y-I, Choi IJ. Endoscopic management of tumor bleeding from inoperable gastric cancer. Clinical Endoscopy. 2015;48(2):121-127.  https://doi.org/10.5946/ce.2015.48.2.121
  77. Kim YI, Choi IJ, Cho SJ, Lee JY, Kim CG, Kim MJ, Ryu KW, Kim YW, Park YI. Outcome of endoscopic therapy for cancer bleeding in patients with unresectable gastric cancer. Journal of Gastroenterology and Hepatology. 2013;28(9):1489-1495. https://doi.org/10.1111/jgh.12262
  78. Kim YJ, Park JC, Kim EH, Shin SK, Lee SK, Lee YC. Hemostatic powder application for control of acute upper gastrointestinal bleeding in patients with gastric malignancy. Endoscopy International Open. 2018;6(6):E700-E705. https://doi.org/10.1055/a-0593-5884
  79. Martins BC, Wodak S, Gusmon CC, Safatle-Ribeiro AV, Kawaguti FS, Baba ER, Pennacchi CM, Lima MS, Ribeiro U Jr, Maluf-Filho F. Argon plasma coagulation for the endoscopic treatment of gastrointestinal tumor bleeding: A retrospective comparison with a non-treated historical cohort. United European Gastroenterology Journal. 2016;4(1):49-54.  https://doi.org/10.1177/2050640615590303
  80. Cho SB, Hur S, Kim HC, Jae HJ, Lee M, Kim M, Kim JE, Lee JH, Chung JW. Transcatheter arterial embolization for advanced gastric cancer bleeding: A single-center experience with 58 patients. Medicine. 2020;99(15):e19630. https://doi.org/10.1097/MD.0000000000019630
  81. Koh KH, Kim K, Kwon DH, Chung BS, Sohn JY, Ahn DS, Jeon BJ, Kim SH, Kim IH, Kim SW, Lee SO, Lee ST, Kim DG. The successful endoscopic hemostasis factors in bleeding from advanced gastric cancer. Gastric Cancer. 2013;16(3):397-403.  https://doi.org/10.1007/s10120-012-0200-3
  82. Meehan T, Stecker MS, Kalva SP, Oklu R, Walker TG, Ganguli S. Outcomes of transcatheter arterial embolization for acute hemorrhage originating from gastric adenocarcinoma. Journal of Vascular and Interventional Radiology. 2014;25(6):847-851.  https://doi.org/10.1016/j.jvir.2014.02.005
  83. Park S, Shin JH, Gwon DI, Kim HJ, Sung KB, Yoon HK, Ko GY, Ko  HK. Transcatheter Arterial Embolization for Gastrointestinal Bleeding Associated with Gastric Carcinoma: Prognostic Factors Predicting Successful Hemostasis and Survival. Journal of Vascular and Interventional Radiology. 2017;28(7):1012-1021. https://doi.org/10.1016/j.jvir.2017.03.017
  84. Lee YH, Lee JW, Jang HS. Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer. BMC Cancer. 2017;17(1):541.  https://doi.org/10.1186/s12885-017-3508-x
  85. Kondoh C, Shitara K, Nomura M, Takahari D, Ura T, Tachibana H, Tomita N, Kodaira T, Muro K. Efficacy of palliative radiotherapy for gastric bleeding in patients with unresectable advanced gastric cancer: a retrospective cohort study. BMC Palliative Care. 2015;14:37.  https://doi.org/10.1186/s12904-015-0034-y
  86. Lee J, Byun HK, Koom WS, Lee YC, Seong J. Efficacy of radiotherapy for gastric bleeding associated with advanced gastric cancer. Radiation Oncology. 2021;16(1):161.  https://doi.org/10.1186/s13014-021-01884-5
  87. Tanaka O, Sugiyama A, Omatsu T, Tawada M, Makita C, Matsuo M. Hemostatic radiotherapy for inoperable gastric cancer: a pilot study. The British Journal of Radiology. 2020;93(1111):20190958. https://doi.org/10.1259/bjr.20190958
  88. Troncone E, Fugazza A, Cappello A, Del Vecchio Blanco G, Monteleone G, Repici A, Teoh AYB, Anderloni A. Malignant gastric outlet obstruction: Which is the best therapeutic option? World Journal of Gastroenterology. 2020;26(16):1847-1860. https://doi.org/10.3748/wjg.v26.i16.1847
  89. Shabunin AV, Lebedev SS, Chechenin GM, Barinov YuV, Sidorova YuV, Bagateliya ZA, Vardanyan AV, Dolidze DD. Opyt primeneniya metallicheskikh samorasshiryayushchikhsya stentov pri zlokachestvennoy obstruktsii vykhodnogo otdela zheludka i dvenadtsatiperstnoy kishki. Khirurgiya. Zhurnal im. N.I. Pirogova. 2017;8:47-50. (In Russ.). https://doi.org/10.17116/hirurgia2017847-50
  90. Rodríguez JI, Kutscher M, Lemus M, Crovari F, Pimentel F, Briceño E. Palliative gastrojejunostomy in unresectable cancer and gastric outlet obstruction: a retrospective cohort study. Annals of the Royal College of Surgeons of England, 2021;103(3):197-202.  https://doi.org/10.1308/rcsann.2020.7016
  91. Upchurch E, Ragusa M, Cirocchi R. Stent placement versus surgical palliation for adults with malignant gastric outlet obstruction. The Cochrane Database of Systematic Reviews. 2018;5:CD012506. https://doi.org/10.1002/14651858.CD012506.pub2
  92. Yamao K, Kitano M, Chiba Y, Ogura T, Eguchi T, Moriyama I, Yamashita Y, Kato H, Kayahara T, Hoki N, Okabe Y, Shiomi H, Nakai Y, Kushiyama Y, Fujimoto Y, Hayashi S, Bamba S, Kudo Y, Azemoto N, Ueki T, Uza N, Asada M, Matsumoto K, Nebiki H, Takihara H, Noguchi C, Kamada H, Nakase K, Goto D, Sanuki T, Koga T, Hashimoto S, Nishikiori H, Serikawa M, Hanada K, Hirao K, Ohana M, Kazuyuki I, Kato T, Yoshida M, Kawamoto H. Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction. Gut. 2021;70(7):1244-1252. https://doi.org/10.1136/gutjnl-2020-320775
  93. Hamada T, Hakuta R, Takahara N, Sasaki T, Nakai Y, Isayama H, Koike K. Covered versus uncovered metal stents for malignant gastric outlet obstruction: Systematic review and meta-analysis. Digestive Endoscopy. 2017;29(3):259-271.  https://doi.org/10.1111/den.12786
  94. Saeed SM, Bilal S, Siddique MZ, Saqib M, Shahid S, Ghumman AN, Yusuf MA. Pyloric stent insertion in malignant gastric outlet obstruction: moving beyond palliation. Therapeutic Advances in Gastrointestinal Endoscopy. 2021;14:26317745211047012. https://doi.org/10.1177/26317745211047012
  95. Jeurnink SM, van Eijck CH, Steyerberg EW, Kuipers EJ, Siersema PD. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterology. 2007;7:18.  https://doi.org/10.1186/1471-230X-7-18
  96. Hong J, Chen Y, Li J, Hu P, Chen P, Du N, Huang T, Chen J. Comparison of gastrojejunostomy to endoscopic stenting for gastric outlet obstruction: An updated Systematic Review and Meta-analysis. American Journal of Surgery. 2022;223(6):1067-1078. https://doi.org/10.1016/j.amjsurg.2021.10.038
  97. Perez-Miranda M, Tyberg A, Poletto D, Toscano E, Gaidhane M, Desai AP, Kumta NA, Fayad L, Nieto J, Barthet M, Shah R, Brauer BC, Sharaiha RZ, Kahaleh M. EUS-guided Gastrojejunostomy Versus Laparoscopic Gastrojejunostomy: An International Collaborative Study. Journal of Clinical Gastroenterology. 2017;51(10):896-899.  https://doi.org/10.1097/MCG.0000000000000887
  98. Tonozuka R, Tsuchiya T, Mukai S, Nagakawa Y, Itoi T. Endoscopic Ultrasonography-Guided Gastroenterostomy Techniques for Treatment of Malignant Gastric Outlet Obstruction. Clinical Endoscopy. 2020;53(5):510-518.  https://doi.org/10.5946/ce.2020.151
  99. Khashab MA, Kumbhari V, Grimm IS, Ngamruengphong S, Aguila G, El Zein M, Kalloo AN, Baron TH. EUS-guided gastroenterostomy: the first U.S. clinical experience (with video). Gastrointestinal Endoscopy. 2015;82(5):932-938.  https://doi.org/10.1016/j.gie.2015.06.017
  100. Carbajo AY, Kahaleh M, Tyberg A. Clinical Review of EUS-guided Gastroenterostomy (EUS-GE). Journal of Clinical Gastroenterology. 2020;54(1):1-7.  https://doi.org/10.1097/MCG.0000000000001262
  101. Itoi T, Ishii K, Ikeuchi N, Sofuni A, Gotoda T, Moriyasu F, Dhir V, Teoh AY, Binmoeller KF. Prospective evaluation of endoscopic ultrasonography-guided double-balloon-occluded gastrojejunostomy bypass (EPASS) for malignant gastric outlet obstruction. Gut. 2016;65(2):193-195.  https://doi.org/10.1136/gutjnl-2015-310348
  102. Ge PS, Young JY, Dong W, Thompson CC. EUS-guided gastroenterostomy versus enteral stent placement for palliation of malignant gastric outlet obstruction. Surgical Endoscopy. 2019;33(10):3404-3411. https://doi.org/10.1007/s00464-018-06636-3
  103. Kerdsirichairat T, Irani S, Yang J, Brewer Gutierrez OI, Moran R, Sanaei O, Dbouk M, Kumbhari V, Singh VK, Kalloo AN, Khashab MA. Durability and long-term outcomes of direct EUS-guided gastroenterostomy using lumen-apposing metal stents for gastric outlet obstruction. Endoscopy International Open. 2019;7(2):E144-E150. https://doi.org/10.1055/a-0799-9939
  104. Chernousov AF, Khorobrykh TV, Vetshev FP. Laparoscopic operations in the treatment of complicated forms of gastric cancer. Research and practice in medicine. 2019;6(S):290. (In Russ.).
  105. Chen XJ, Chen GM, Wei YC, Yu H, Wang XC, Zhao ZK, Luo TQ, Nie RC, Zhou ZW. Palliative Gastrectomy versus Gastrojejunostomy for advanced Gastric cancer with outlet obstruction: a propensity score matching analysis. BMC Cancer. 2021;21(1):188.  https://doi.org/10.1186/s12885-021-07904-7
  106. Dibirov MD, Khalidov OKh, Zakaraya AE. Gastric cancer complicated by perforation and stenosis in emergency abdominal surgery. Moscow surgical journal. 2010;5(15):7-10. (In Russ.).
  107. Lin C, Fan H, Chen W, Cui L. Palliative Gastrectomy vs. Gastrojejunostomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis. Frontiers in Surgery. 2021;8:723065. https://doi.org/10.3389/fsurg.2021.723065
  108. Abdel-lah-Fernández O, Parreño-Manchado FC, García-Plaza A, Álvarez-Delgado A. Gastro yeyuno anastomosis con separación gástrica parcial en el tratamiento de la obstrucción gastroduodenal secundaria a cáncer gástrico avanzado [Partial stomach partitioning gastrojejunostomy in the treatment of the malignant gastric outlet obstruction]. Cirugia y Cirujanos. 2015;83(5):386-392.  https://doi.org/10.1016/j.circir.2015.05.034
  109. Lorusso D, Giliberti A, Bianco M, Lantone G, Leandro G. Stomach-partitioning gastrojejunostomy is better than conventional gastrojejunostomy in palliative care of gastric outlet obstruction for gastric or pancreatic cancer: a meta-analysis. Journal of Gastrointestinal Oncology. 2019;10(2):283-291.  https://doi.org/10.21037/jgo.2018.10.10
  110. Ishida H, Cho H, Tsuchida K, Onoyama H, Maezawa Y. Laparoscopic stomach-partitioning gastrojejunostomy in preparation for distal gastrectomy and Billroth-II reconstruction after neoadjuvant chemotherapy for advanced gastric cancer with gastric outlet obstruction: A case report. Asian Journal of Endoscopic Surgery. 2020;13(3):415-418.  https://doi.org/10.1111/ases.12741
  111. Ramos MFKP, Barchi LC, de Oliveira RJ, Pereira MA, Mucerino DR, Ribeiro U Jr, Zilberstein B, Cecconello I. Gastric partitioning for the treatment of malignant gastric outlet obstruction. World Journal of Gastrointestinal Oncology. 2019;11(12):1161-1171. https://doi.org/10.4251/wjgo.v11.i12.1161
  112. Yasufuku I, Ohashi M, Makuuchi R, Hayami M, Ida S, Kumagai K, Sano T, Nunobe S. High prevalence of peritoneal metastasis in gastric cancer presenting gastric outlet obstruction: A new candidate for consecutive diagnostic staging laparoscopy and laparoscopic gastrojejunostomy. European Journal of Surgical Oncology. 2022;48(8):1746-1752. https://doi.org/10.1016/j.ejso.2022.01.011

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.